A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma

NCT00431990 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: depsipeptide
DRUG: bortezomib
DRUG: dexamethasone

Sponsor

Peter MacCallum Cancer Centre, Australia

Collaborators

[object Object]
[object Object]